Skip to main content
. Author manuscript; available in PMC: 2006 Jun 27.
Published in final edited form as: Am J Cardiol. 2005 May 1;95(9):1060–1064. doi: 10.1016/j.amjcard.2004.12.058

TABLE 3.

Effects of Interventions on Mortality in the Pooled Clinical Trials

Relative Risk
Cause of Death Statistical Comparison Boston8 Oakland6 2 Trials Significance (2 trials)
All cause TM vs usual care 1.13 0.60 0.89 0.21
TM vs other active therapy 0.79 0.58 0.73 0.03
Other active therapy vs usual care 1.33 1.16 1.26 0.43
TM vs combined controls 0.85 0.61 0.77 0.04
Cardiovascular disease TM vs usual care 1.65 0.16 0.82 0.10
TM vs other active therapy 0.80 0.23 0.68 0.06
Other active therapy vs usual care 1.79 0.69 1.23 0.74
TM vs combined controls 0.92 0.19 0.70 0.05
Cancer TM vs usual care 0.54 0.69 0.65 0.47
TM vs other active therapy 0.20 0.69 0.44 0.09
Other active therapy vs usual care 2.49 1.25 1.56 0.52
TM vs combined controls 0.24 0.73 0.51 0.15